<DOC>
	<DOCNO>NCT00277199</DOCNO>
	<brief_summary>Study Compare Pharmacokinetics CD-CHO1 Process BMS-188667 DE Process BMS-188667 Healthy Subjects</brief_summary>
	<brief_title>Comparability DE v CD-CHO1</brief_title>
	<detailed_description />
	<mesh_term>Abatacept</mesh_term>
	<criteria>Signed consent form Healthy subject determine good health determine clinically significant deviation normal medical history , physical examination , ECGs clinical laboratory determination . Body weight subject &lt; 100 kg . body Mass Index ( BMI ) 1830 kg/m2 inclusive ; BMI = weight ( kg ) / [ height ( ) ] 2 Men woman ( nursing , prgnant ) , least 18 year age . Women childbearing potential ( WOCBP ) must use adequate method contraception avoid pregnancy throughout study least 4 week 10 week infusion BMS188667 manner risk pregnancy minimize . WOCBP males unwilling unable use acceptable method avoid pregnancy 10 week infusion BMS1886678 . WOCBP must also use acceptable method contraception least 1 month dosing . Women pregnant ore breastfeed . Women positive pregnanacy tes enrollment prior study drug administration . History current evidence signiicant acute chroinic medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>